Immunosuppressant and neuromyelitis optica spectrum disorder: optimal treatment duration and risk of discontinuation.

Rui LiCong LiQiao HuangZifeng LiuJingjing ChenBingjun ZhangChunxin LiuYaqing ShuYuge WangAllan G Kermode Wei Qiu

Published in: European journal of neurology (2022)

Long-term IS medication for NMOSD is generally suitable. Patients with longitudinal extensive transverse myelitis had a higher risk of relapse after IS discontinuation. Future studies should explore individualized strategies of rituximab maintenance treatment.

Keyphrases

spectrum disorder
healthcare
emergency department
cross sectional
diffuse large b cell lymphoma
combination therapy
current status
chronic lymphocytic leukemia
electronic health record